M.P. Evans Group PLC (MPE) — Investment Research Note

Executive summary

M.P. Evans is an AIM-listed producer of sustainable Indonesian palm oil that owns and manages ~70,000 planted hectares across six estates in Sumatra and East Kalimantan, processing crop through six on-site mills and selling crude palm oil (CPO) and palm kernels (PK) primarily into Indonesian refineries 2026-03-24 final results. The operating trajectory across 2021–2025 has been one of steady crop growth (12% in 2021, 11% in 2022, 7% in 2023 in own crop, 7% in 2025) combined with two cycles of elevated palm-oil pricing (war-driven 2022 spike, sustained 2024–2025 strength) culminating in record gross profit of US$142.2m in 2025, EPS of 161.3p, and a net cash position of US$87.5m 2026-03-24. The single most important point for valuation is that 2024–2025 earnings reflect a combination of mature-estate volume gains AND elevated CPO prices (~US$823–866/t mill-gate) — through-cycle pricing closer to US$700/t would compress earnings materially, so the current 9.7× P/E is on cyclically elevated numbers.

Fair value estimate

Range: 1,500p – 1,900p per share. Implied market cap: £780m – £988m.

Methodology — triangulation between (i) through-cycle earnings multiple and (ii) NAV based on independent hectare valuations:

• Through-cycle earnings: 2025 EPS 161.3p, 2024 EPS 129.6p, 2023 EPS 78.1p (cycle low). Mid-cycle EPS estimate ~130p × 9–11× P/E for a quality but cyclical plantation = 1,170–1,430p, plus net cash of ~125p/share → ~1,300–1,560p.
• NAV: Independent valuation at end-2023 reported $18,400/planted hectare and £14.98/share equity value 2024-03-19 final results; using $18,500–20,000/ha across ~70,000 hectares gives plantation value ~$1.3–1.4bn, plus net cash $87.5m, less minorities/pensions → ~1,800–2,100p/share NAV.
• 2026 YTD: crop +10%, CPO ~US$830/t (slightly softer), PK +7% 2026-06-12 trading. Cost stable.

Midpoint ~1,700p vs current 1,566p = ~+8% upside. Range is fair-to-modestly-undervalued.

Sector context

ICB classification: Food, Beverage & Tobacco (Consumer Staples) — confirmed, though the business behaves much more like a soft commodity / agribusiness than a defensive staple. Quality profile is above typical AIM-listed plantation peers on balance-sheet strength (net cash vs. typical net debt), governance, and sustainability certification (RSPO across all six mills); growth is in line; leverage is well below peers.

Listed comparables: Anglo-Eastern Plantations (AEP, AIM), R.E.A. Holdings (RE., LSE), and larger but relevant Asian-listed names like United Plantations (Bursa) and Genting Plantations.

Investment thesis

1. Mature growth pipeline with embedded margin uplift from own-crop mix-shift. Continued acquisition strategy (3,000 ha at Bumi Mas in 2025, 8,350 ha at Kota Bangun in 2023, 2,750 ha SKMA/SBS) plus organic planting at Musi Rawas is lifting Group-managed hectarage 30%+ over three years, while deliberately throttling lower-margin third-party crop purchases. Own crop processed at higher extraction rates (24.2% YTD 2026 vs 23.5% in 2025) drives gross-margin expansion — gross margin moved from 26% in 2023 to 33% in 2024 to 38% in H1 2025 2026-03-24 and 2025-09-15 H1.
2. Fortress balance sheet with progressive dividend and buybacks. Net cash US$87.5m, zero borrowings as at end-2025, 35-year unbroken record of maintained-or-rising dividends, total 2025 dividend of 60p (P/Y 52.5p) and restarted share buyback at £15/share average 2026-06-12 trading; 2026-03-24. Dividend yield ~3.8% supported by US$161.5m operating cash generation.
3. Valuation underpin from independent hectare values. Group equity NAV reported at £14.98/share at end-2023 — independent annual valuations have run at $18,400–18,500/ha; current price embeds little premium over conservative plantation NAV despite the cash pile and progressive distribution policy 2024-03-19.

Key risks

1. CPO price cyclicality and Indonesian policy risk. CPO mill-gate pricing has been a US$700–1,000/t corridor; 2026 export rule changes flagged by Jakarta could affect realisations even though MPE sells domestically 2026-06-12 trading. A 10% CPO price decline would compress operating profit disproportionately given the high operating leverage in reverse.
2. Geographic and political concentration in Indonesia. All productive assets are in Sumatra and East Kalimantan; the Satgas regulatory review under President Prabowo (since late 2024) has levied fines and reclaimed land elsewhere in the sector — MPE reports no material impact "to date" but the risk is live 2026-03-24.
3. Input-cost inflation (fertiliser, diesel) and weather/El Niño exposure. First-half 2025 cost reductions partly reflected fertiliser timing, with the H2 fertiliser bill weighted higher; Middle East conflict noted as adding to fuel costs in 2026 2026-06-12.

Operating leverage

MPE is a moderately-to-significantly operating-leveraged plantation business. The cost base is heavily fixed at the field and mill level — labour, mill running costs, depreciation on $511m of PP&E, central admin — with the variable element being independent ffb purchases (which the company is deliberately reducing) and fertiliser. The observable leverage: 2025 vs 2024 revenue grew just 5% (US$371m vs $353m), yet gross profit grew 22% (US$142m vs $117m) and operating profit grew 20% (US$139m vs $116m) — an incremental revenue-to-profit conversion of roughly 4:1 2026-03-24. H1 2025 was even more dramatic: revenue +10%, but gross profit +51% and operating profit +50% as the own-crop mix improved 2025-09-15. Spare mill capacity at Bumi Mas (acquired hectarage now feeding utilization) is a near-term inflection point. However, this leverage is price-driven rather than secular: a 10–20% CPO price beat would plausibly add ~50% to operating profit, but a 10–20% price miss would do the reverse. Not the high-fixed-cost software-style leverage the investor profile targets.

Value-trap signals

None identified. Disclosure is clean, dividends are rising, balance sheet is in net cash, the auditor (BDO) issues unqualified opinions, NCI buyouts have been done at sensible prices, and the prior-year accounting restatement in 2025 was a technical (goodwill/DTL) adjustment that reduced reported liabilities, not earnings. Voting outcomes show some minority dissent on remuneration but not at problematic levels.

Earnings vs expectations

The filings carry limited formal guidance and no analyst consensus references, so this is a qualitative read. Year-end results have been described as "record" each year from 2023 onwards 2024-03-19, 2025-03-25, 2026-03-24; AGM trading updates have consistently flagged crop volumes ahead of prior year, and H1 2025 delivered a 60% EPS jump (71.7p vs 44.9p) versus a measured outlook set in early 2025 2025-09-15. The pattern is consistent positive surprises at the operational level, with results above the conservative tone management strikes in interim statements — though the upside is largely commodity-driven, not management-driven.

Conviction

4 — high. Anchored by: (i) audited, well-disclosed financials with clean cash conversion (operating cash US$161.5m on US$139m operating profit); (ii) independent annual hectare valuations giving a defensible NAV floor; (iii) clear and stable strategy executed predictably. Limited by: (i) cyclicality of CPO pricing — the central fair-value estimate is sensitive to a through-cycle price assumption that could be high or low by 15%, and (ii) Indonesian regulatory tail risk that is impossible to size precisely.

Driver scoring rationale

For this investor profile (AI-receiver, operating leverage, valuation discipline, downside protection), MPE has effectively zero AI exposure — it's an agricultural commodity producer. It scores well on balance-sheet quality, management, and earnings quality, and is reasonably priced, but fails the headline test. Overall score reflects that mismatch.